82 Participants Needed

Self-Management Program for Depression and High Blood Pressure Risk

(TEAM-Red Trial)

TM
Overseen ByTaylor Maniglia
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Jennifer B. Levin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using antihypertensive medications (medications for high blood pressure).

What data supports the effectiveness of the treatment TEAM-Red for managing depression and high blood pressure risk?

Research shows that integrating depression treatment into hypertension care can improve both blood pressure control and depressive symptoms. Additionally, self-management programs and interventions that consider social factors have been effective in improving health outcomes for patients with both conditions.12345

Is the Self-Management Program for Depression and High Blood Pressure Risk safe for humans?

The available research does not provide specific safety data for the Self-Management Program for Depression and High Blood Pressure Risk, but similar team-based care programs for managing hypertension and depression have been implemented without reported safety concerns.678910

How is the TEAM-Red treatment different from other treatments for depression and high blood pressure?

TEAM-Red is unique because it integrates depression treatment into hypertension care, using a team-based approach involving Licensed Practical Nurses (LPNs) to improve both blood pressure control and depressive symptoms, unlike traditional treatments that often address these conditions separately.1381112

Research Team

JL

Jennifer Levin, PhD

Principal Investigator

University Hospitals Cleveland Medical Center

Eligibility Criteria

This trial is for young African-American women under 50 with depression and at risk for high blood pressure, but not yet diagnosed with it. Participants must have a BMI ≥30, HbA1c >5.75, a recent BP reading of ≥130/90 mmHg, be current smokers or have LDL levels ≥100 mg/dl.

Inclusion Criteria

I have high blood pressure risk due to factors like being overweight, high blood sugar, high blood pressure readings, smoking, or high cholesterol.
I can follow the study's required procedures.
You have a score of 10 or more on the 9-item Patient Health Questionnaire (PHQ-9), which measures depression.
See 5 more

Exclusion Criteria

I have high blood pressure or am taking medication for it.
Unwilling/unable to provide informed consent
Pregnancy
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the TEAM-Red intervention or are placed on an enhanced waitlist control for 24 weeks

24 weeks
5 group sessions (remote)

Follow-up

Participants are monitored for changes in depression and stress levels using PHQ-9 and PSS-10 scores

12 weeks

Treatment Details

Interventions

  • TEAM-Red
  • Waitlist
Trial Overview The study compares the TEAM-Red self-management program against an enhanced waitlist control over 24 weeks to see if it helps manage risks associated with hypertension in depressed Black women who are predisposed to high blood pressure.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: TEAM-RedExperimental Treatment1 Intervention
Five 60-minute group sessions with 6-10 patients. These sessions will be held weekly and delivered remotely via videoconference
Group II: Enhanced Waitlist (eWL)Experimental Treatment1 Intervention
After the week 12 follow up visit, subjects in the Waitlist group will receive the TEAM Red intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jennifer B. Levin

Lead Sponsor

Trials
1
Recruited
80+

American Heart Association

Collaborator

Trials
352
Recruited
6,196,000+

Findings from Research

An integrated care intervention led by Licensed Practical Nurses (LPNs) significantly improved blood pressure control and reduced depressive symptoms in patients with hypertension, with diastolic blood pressure dropping from 82.0 mmHg in usual care to 74.2 mmHg in the intervention group after 12 weeks.
Patients receiving the integrated care also showed a notable decrease in depressive symptoms, with average PHQ-9 scores improving from 7.1 in usual care to 2.4 in the intervention group, highlighting the effectiveness of combining depression treatment with hypertension management.
Pilot trial of a licensed practical nurse intervention for hypertension and depression.Bogner, HR., de Vries, HF., Kaye, EM., et al.[2022]
Self-management interventions significantly improve patient activation levels in adults with hypertension, based on a systematic review of 4 studies involving 1415 participants.
Strategies such as community-based programs and motivational interviewing were particularly effective, leading to better patient activation measure (PAM) scores compared to usual care.
Impact of Behavioral Interventions on Patient Activation in Adults with Hypertension: A Systematic Review and Meta-Analysis.Innab, A., Kerari, A.[2022]
In a study of 318 patients with primary hypertension, self-efficacy was found to be a key mediator between social support and self-care behaviors related to diet and weight management, highlighting its importance in managing hypertension.
Depressive symptoms also played a significant role, mediating the relationship between social support and self-efficacy, suggesting that addressing mental health is crucial for improving self-care in hypertensive patients.
Factors influencing self-care among patients with primary hypertension: path analysis of mediating roles of self-efficacy and depressive symptoms.Chen, TY., Kao, CW., Cheng, SM., et al.[2023]

References

Pilot trial of a licensed practical nurse intervention for hypertension and depression. [2022]
Impact of Behavioral Interventions on Patient Activation in Adults with Hypertension: A Systematic Review and Meta-Analysis. [2022]
Factors influencing self-care among patients with primary hypertension: path analysis of mediating roles of self-efficacy and depressive symptoms. [2023]
Incorporating Patients' Social Determinants of Health into Hypertension and Depression Care: A Pilot Randomized Controlled Trial. [2022]
Influence of "Hospital-Community-Family" Integrated Management on Blood Pressure, Quality of Life, Anxiety and Depression in Hypertensive Patients. [2022]
A multi-level system quality improvement intervention to reduce racial disparities in hypertension care and control: study protocol. [2022]
A Mixed-Methods Approach for Evaluating Implementation Processes and Program Costs for a Hypertension Management Program Implemented in a Federally Qualified Health Center. [2023]
Primary care physician perspectives on using team care in clinical practice. [2021]
Technology-Assisted Collaborative Care Program for People with Diabetes and/or High Blood Pressure Attending Primary Health Care: A Feasibility Study. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Efficacy of Hypertension Self-Management Classes Among Patients at a Federally Qualified Health Center. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Psychometric Evaluation of the Chinese Version of Hypertension Self-care Profile. [2021]
Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial. [2018]